The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 04, 2025

Filed:

May. 08, 2023
Applicant:

Zumutor Biologics Inc., Cambridge, MA (US);

Inventors:

Kavitha Iyer Rodrigues, Bangalore, IN;

Maloy Ghosh, Bangalore, IN;

Sunit Maity, Bangalore, IN;

Yogendra Manjunath Bangalore Muniraju, Bangalore, IN;

Sathyabalan Murugesan, Bangalore, IN;

Sanghamitra Bhattacharjee, Bangalore, IN;

Vivek Halan, Bangalore, IN;

Subhra Prakash Chakrabarty, Bangalore, IN;

Ashvini Kumar Dubey, Bangalore, IN;

Anurag Tiwari, Bangalore, IN;

Kirthana Mysore Vasudevarao Sindhe, Bangalore, IN;

Pallavi Lahiri, Bangalore, IN;

Sahana Bhima Rao, Bangalore, IN;

Prachi, Bangalore, IN;

Shruti Srivastava, Bangalore, IN;

Rao Shreesha Ramesh, Bangalore, IN;

Bharath Ravindra Shenoy, Bangalore, IN;

Nikitha Markanda, Bangalore, IN;

Bhagyashree Dikey, Bangalore, IN;

Bairavabalakumar Natarajan, Bangalore, IN;

Assignee:

Zumutor Biologics Inc., Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/00 (2006.01); A61K 40/11 (2025.01); A61K 40/15 (2025.01); A61K 40/42 (2025.01); A61P 35/00 (2006.01); C12N 5/071 (2010.01); C12N 15/10 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2851 (2013.01); A61K 40/11 (2025.01); A61K 40/15 (2025.01); A61K 40/42 (2025.01); A61P 35/00 (2018.01); C12N 5/0602 (2013.01); C12N 15/1055 (2013.01); A61K 2039/505 (2013.01); C07K 2317/41 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/734 (2013.01); C07K 2317/92 (2013.01);
Abstract

The present disclosure relates to novel anti-CLEC2D antibodies and related compositions and methods of use thereof These antibodies are used as therapeutics, and in prognostic and diagnostic applications in various cancers and other diseases.


Find Patent Forward Citations

Loading…